Overall, this work highlights the clinical potential of GC-PDCOs to guide personalized therapy, predict treatment response, and uncover mechanisms of resistancebridging the gap between bench research and bedside decision-making in precision oncology
Small research studies and anecdotal clinical reports suggest that some people tolerate DSIP without major side effects, but standardized long-term safety studies do not exist
Scientists developed it as a triple hormone receptor agonist , meaning it activates three different metabolic pathways in the body
As with any therapeutic compound, application under physician guidance is recommended to ensure appropriate concentration and formulation
Uversky, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
For most adults and older children, the soreness lessens within a few days
